Sign in

CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471144582
Phone
781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,050,832
in 7 filings, $404K under 10b5-1 plans

Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 79 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-01 Ticho Barry CHIEF MEDICAL OFFICER Option exercise 10b5-1 +10,000 $0.60 $6K 12,485
2024-05-01 Ticho Barry CHIEF MEDICAL OFFICER Sale 10b5-1 −10,000 $11.37 $114K 2,485
2024-05-01 Ticho Barry CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 70,000
2024-04-17 Skorpios Trust 10% owner Sale −3,600,000 $11.60 $41.8M 10,843,681
2024-04-01 Ticho Barry CHIEF MEDICAL OFFICER Option exercise 10b5-1 +442 $0.60 $265 11,911
2024-04-01 Ticho Barry CHIEF MEDICAL OFFICER Sale 10b5-1 −9,426 $13.23 $125K 2,485
2024-04-01 Ticho Barry CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −442 80,000
2024-04-01 Nash Huw M. COO & CBO Option exercise 10b5-1 +50,000 $0.40 $20K 61,329
2024-04-01 Nash Huw M. COO & CBO Sale 10b5-1 −60,929 $13.22 $806K 400
2024-04-01 Nash Huw M. COO & CBO Sale 10b5-1 −400 $13.61 $5K 0
2024-04-01 Nash Huw M. COO & CBO Option exercise · Stock Option (Right to Buy) 10b5-1 −50,000 96,000
2024-03-28 Allan Jonathan GENERAL COUNSEL & CORP SEC Sale 10b5-1 −5,026 $13.19 $66K 2,698
2024-03-28 Allan Jonathan GENERAL COUNSEL & CORP SEC Sale 10b5-1 −100 $13.81 $1K 2,598
2024-03-27 Kaye Edward M. MD CEO Grant or award · Employee Stock Option (Right to Buy) +159,000 159,000
2024-03-27 Kaye Edward M. MD CEO Grant or award · Restricted Stock Units +105,000 105,000
2024-03-27 Nash Huw M. COO & CBO Grant or award · Employee Stock Option (Right to Buy) +60,000 60,000
2024-03-27 Nash Huw M. COO & CBO Grant or award · Restricted Stock Units +40,000 40,000
2024-03-27 Ticho Barry CHIEF MEDICAL OFFICER Grant or award · Employee Stock Option (Right to Buy) +60,000 60,000
2024-03-27 Ticho Barry CHIEF MEDICAL OFFICER Grant or award · Restricted Stock Units +40,000 40,000
2024-03-27 Allan Jonathan GENERAL COUNSEL & CORP SEC Grant or award · Employee Stock Option (Right to Buy) +36,000 36,000

Page 17 of 24 · 461 trades